1. Home
  2. HALO vs MTN Comparison

HALO vs MTN Comparison

Compare HALO & MTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • MTN
  • Stock Information
  • Founded
  • HALO 1998
  • MTN 1997
  • Country
  • HALO United States
  • MTN United States
  • Employees
  • HALO N/A
  • MTN N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • MTN Services-Misc. Amusement & Recreation
  • Sector
  • HALO Health Care
  • MTN Consumer Discretionary
  • Exchange
  • HALO Nasdaq
  • MTN Nasdaq
  • Market Cap
  • HALO 7.5B
  • MTN 6.4B
  • IPO Year
  • HALO N/A
  • MTN 1997
  • Fundamental
  • Price
  • HALO $52.28
  • MTN $171.12
  • Analyst Decision
  • HALO Buy
  • MTN Buy
  • Analyst Count
  • HALO 9
  • MTN 9
  • Target Price
  • HALO $60.44
  • MTN $205.44
  • AVG Volume (30 Days)
  • HALO 1.5M
  • MTN 675.5K
  • Earning Date
  • HALO 11-04-2024
  • MTN 12-05-2024
  • Dividend Yield
  • HALO N/A
  • MTN 5.17%
  • EPS Growth
  • HALO 51.77
  • MTN N/A
  • EPS
  • HALO 2.58
  • MTN 6.07
  • Revenue
  • HALO $873,304,000.00
  • MTN $2,885,191,000.00
  • Revenue This Year
  • HALO $20.95
  • MTN $5.54
  • Revenue Next Year
  • HALO $16.35
  • MTN $3.22
  • P/E Ratio
  • HALO $20.23
  • MTN $28.31
  • Revenue Growth
  • HALO 12.88
  • MTN N/A
  • 52 Week Low
  • HALO $32.83
  • MTN $165.14
  • 52 Week High
  • HALO $65.53
  • MTN $236.92
  • Technical
  • Relative Strength Index (RSI)
  • HALO 37.84
  • MTN 40.85
  • Support Level
  • HALO $49.63
  • MTN $170.18
  • Resistance Level
  • HALO $54.66
  • MTN $176.10
  • Average True Range (ATR)
  • HALO 2.24
  • MTN 3.87
  • MACD
  • HALO -0.30
  • MTN -0.39
  • Stochastic Oscillator
  • HALO 21.42
  • MTN 26.88

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About MTN Vail Resorts Inc.

Vail Resorts Inc Bhd is a resorts and casinos company that operates mountain resorts and ski areas. The company has three business segments that include Mountain, Lodging, and Real Estate. The Mountain segment operates numerous ski resort properties that offer a variety of winter and summer activities, such as skiing, snowboarding, snowshoeing, hiking, and mountain biking. The Lodging segment owns and operates hotels and condominiums. The Real Estate segment owns, develops, and leases real estate, typically near its other properties. The company generates the vast majority of its revenue within the United States.

Share on Social Networks: